Literature DB >> 2891044

Further studies on (+/-)-YM-12617, a potent and selective alpha 1-adrenoceptor antagonist and its individual optical enantiomers.

K Honda1, C Nakagawa, M Terai.   

Abstract

YM-12617, 5-[2-[[2-(o-ethoxyphenoxy)ethyl]amino]propyl]- 2-methoxybenzenesulfonamide HCl is structurally novel, an extremely potent and highly selective alpha 1-adrenoceptor antagonist. An asymmetric center exists at the alpha-carbon atom in the phenethylamine portion of YM-12617, therefore two optical enantiomers exist. alpha-Adrenoceptor blocking properties and hypotensive activities of YM-12617 and its enantiomers have been compared in vitro and in vivo. 1. In the isolated rabbit aorta, R(-)- and S(+)-YM-12617 competitively antagonized phenylephrine-induced contraction with pA2 values of 9.95 and 7.69, respectively. Although R(-)- and S(+)-YM-12617 were also competitive antagonists toward UK-14,304 at prejunctional alpha 2-adrenoceptors in the isolated guinea-pig ileum, the affinities of R(-)-YM-12617 (pA2 = 6.18) and S(+)-YM-12617 (pA2 = 5.64) for these receptors were 5,900 and 110 times lower than those displayed for postjunctional alpha 1-adrenoceptors in the isolated rabbit aorta. 2. R(-)- and S(+)-YM-12617 displaced both 3H-prazosin and 3H-idazoxan binding to rat brain membranes; however, the affinities of the R(-)- and S(+)-enantiomers for alpha 1-adrenoceptors (pKi = 9.95 and 7.83, respectively) were 21,000 and 72 times higher than those for alpha 2-adrenoceptors (pKi = 5.62 and 5.97), respectively. 3. Based on pA2 values obtained in the isolated tissues and pKi values in the binding assays, R(-)-YM-12617 was 132-182 times more potent than S(+)-YM-12617 as an antagonist at alpha 1-adrenoceptors. In contrast, the R(-)- and S(+)-enantiomers were similar in potency at blocking alpha 2-adrenoceptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891044     DOI: 10.1007/bf00172681

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  New sulfamoylphenethylamines, potent alpha 1-adrenoceptor antagonists.

Authors:  T Takenaka; K Honda; T Fujikura; K Niigata; S Tachikawa; N Inukai
Journal:  J Pharm Pharmacol       Date:  1984-08       Impact factor: 3.765

2.  A difference in mode of antagonism between optical isomers of a potent selective alpha 1-adrenoceptor blocker (YM-12617) and norepinephrine in isolated rabbit iris dilator and aorta.

Authors:  I Takayanagi; F Konno; H Kameda; H Kubo; A Furukawa; T Toyoda
Journal:  Jpn J Pharmacol       Date:  1986-12

Review 3.  Alpha-adrenoceptor subclassification.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1981       Impact factor: 5.545

Review 4.  Use of isolated, physiologically responding tissues to investigate neurotransmitter receptors.

Authors:  R R Ruffolo
Journal:  Monogr Neural Sci       Date:  1984

5.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

6.  Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).

Authors:  K Honda; T Takenaka; A Miyata-Osawa; M Terai
Journal:  J Pharmacol Exp Ther       Date:  1986-03       Impact factor: 4.030

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.

Authors:  J C Doxey; A G Roach; C F Smith
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

9.  Alpha-1 adrenoceptor antagonist effects of the optical isomers of YM-12617 in rabbit lower urinary tract and prostate.

Authors:  K Honda; C Nakagawa
Journal:  J Pharmacol Exp Ther       Date:  1986-11       Impact factor: 4.030

10.  Adrenoceptor blocking and cardiovascular effects of the optical isomers of amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent, and the corresponding desoxy derivative (YM-11133) in rats.

Authors:  K Honda; C Nakagawa; O Inagaki; M Shibasaki; T Takenaka; M Takeda
Journal:  Jpn J Pharmacol       Date:  1986-08
View more
  2 in total

1.  Role of intracellular Ca2+ stores in smooth muscle contractions of the guinea pig vas deferens.

Authors:  P Drescher; R E Eckert; P O Madsen
Journal:  Urol Res       Date:  1993

2.  Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.

Authors:  D R Blue; D W Bonhaus; A P Ford; J R Pfister; N A Sharif; I A Shieh; R L Vimont; T J Williams; D E Clarke
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.